FIBROUS DYSPLASIA OF BONE
Clinical trials for FIBROUS DYSPLASIA OF BONE explained in plain language.
Never miss a new study
Get alerted when new FIBROUS DYSPLASIA OF BONE trials appear
Sign up with your email to follow new studies for FIBROUS DYSPLASIA OF BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug aims to fix Bone-Weakening phosphate problem in rare disease
Disease control CompletedThis study tested a drug called burosumab in 12 people with fibrous dysplasia who also had low blood phosphate, which can make bones weaker. Participants injected the drug at home once or twice a month for 48 weeks. The main goal was to see if the drug could raise phosphate level…
Matched conditions: FIBROUS DYSPLASIA OF BONE
Phase: PHASE2 • Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New hope for rare bone disease pain?
Disease control CompletedThis study tested a drug called tocilizumab for people with fibrous dysplasia of bone who still had pain after standard treatment. The drug blocks a protein linked to bone breakdown. Nineteen adults participated in this small, early-stage trial to see if the drug could reduce bon…
Matched conditions: FIBROUS DYSPLASIA OF BONE
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Tiny RNA clues may explain bone disease differences
Knowledge-focused CompletedFibrous dysplasia is a rare bone disease that causes pain, fractures, and deformities, but its severity varies widely for unknown reasons. This study looked at 24 adults—some with the disease and some without—to see if small molecules called microRNAs in blood and bone tissue are…
Matched conditions: FIBROUS DYSPLASIA OF BONE
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:12 UTC